Aclaris Therapeutics, Inc. (ACRS) vs Tactile Systems Technology, Inc. (TCMD)
A side-by-side comparison of Aclaris Therapeutics, Inc. and Tactile Systems Technology, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ACRS
Aclaris Therapeutics, Inc.
$3.67HealthcareDelayed quote: Oct 6, 2026, 3:20 PM EDT
TCMD
Tactile Systems Technology, Inc.
$22.19HealthcareDelayed quote: Oct 6, 2026, 3:20 PM EDT
Total return — ACRS vs TCMD
growth of $100 · dividends reinvested · last 10yACRS -83.0% (-16.2%/yr)TCMD +18.1% (+1.7%/yr)TCMD compounded faster over this window
Log scale — wide-divergence pair
ACRS TCMD
ACRS vs TCMD: by the numbers
- •ACRS is the larger company ($512M vs $501M market cap).
- •TCMD is profitable (7.10% net margin) while ACRS runs a net loss (-921.50%).
- •TCMD grew revenue faster over the past five years (11.62% vs 4.39% CAGR).
Metrics side by side
Valuation
| Metric | ACRS | TCMD |
|---|---|---|
| P/E ratio | N/A | 20.55 |
| Forward P/E | N/A | 19.87 |
| P/S ratio | 62.28 | 1.43 |
| P/B ratio | 4.11 | 2.24 |
| EV / EBITDA | N/A | 10.66 |
| FCF yield | N/A | 5.34% |
Profitability
| Metric | ACRS | TCMD |
|---|---|---|
| Gross margin | 73.28% | 74.23% |
| Operating margin | -975.91% | 10.00% |
| Net margin | -921.50% | 7.10% |
| ROE | -60.79% | 11.11% |
| ROIC | -56.99% | 9.54% |
Growth (annualized)
| Metric | ACRS | TCMD |
|---|---|---|
| Revenue CAGR (5Y) | 4.39% | 11.62% |
| FCF CAGR (5Y) | N/A | 32.09% |
| Total return CAGR (5Y) | -24.23% | -11.73% |
Frequently asked
- Which has grown faster, ACRS or TCMD?
- Over the past five years, TCMD grew revenue faster — ACRS at a 4.39% CAGR versus TCMD at 11.62%.
- Is ACRS or TCMD more profitable?
- TCMD runs the higher net margin — ACRS at -921.50% versus TCMD at 7.10%.
- How have ACRS and TCMD total returns compared?
- Over the past 10 years, ACRS delivered -16.23% and TCMD delivered 1.68% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Tactile Systems Technology P/E ratioAclaris Therapeutics ROETactile Systems Technology ROEAclaris Therapeutics operating marginTactile Systems Technology operating marginAclaris Therapeutics revenue growthTactile Systems Technology revenue growthAclaris Therapeutics free cash flowTactile Systems Technology free cash flow
Aclaris Therapeutics & Tactile Systems Technology appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.